Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Decision-support models for empiric antibiotic selection in Gram-negative bloodstream infections.

MacFadden DR, Coburn B, Shah N, Robicsek A, Savage R, Elligsen M, Daneman N.

Clin Microbiol Infect. 2019 Jan;25(1):108.e1-108.e7. doi: 10.1016/j.cmi.2018.03.029. Epub 2018 Apr 25.

PMID:
29705558
2.

Utility of prior cultures in predicting antibiotic resistance of bloodstream infections due to Gram-negative pathogens: a multicentre observational cohort study.

MacFadden DR, Coburn B, Shah N, Robicsek A, Savage R, Elligsen M, Daneman N.

Clin Microbiol Infect. 2018 May;24(5):493-499. doi: 10.1016/j.cmi.2017.07.032. Epub 2017 Aug 12.

3.

Electronic Syndromic Surveillance for Influenza-Like Illness Across Treatment Settings.

Ridgway JP, Lauderdale D, Thisted R, Robicsek A.

Infect Control Hosp Epidemiol. 2017 Apr;38(4):393-398. doi: 10.1017/ice.2016.299. Epub 2016 Dec 19.

PMID:
27989247
4.

Reduction of methicillin-resistant Staphylococcus aureus infection in long-term care is possible while maintaining patient socialization: A prospective randomized clinical trial.

Peterson LR, Boehm S, Beaumont JL, Patel PA, Schora DM, Peterson KE, Burdsall D, Hines C, Fausone M, Robicsek A, Smith BA.

Am J Infect Control. 2016 Dec 1;44(12):1622-1627. doi: 10.1016/j.ajic.2016.04.251. Epub 2016 Aug 1.

5.

Bacterial and viral co-infections complicating severe influenza: Incidence and impact among 507 U.S. patients, 2013-14.

Shah NS, Greenberg JA, McNulty MC, Gregg KS, Riddell J 4th, Mangino JE, Weber DM, Hebert CL, Marzec NS, Barron MA, Chaparro-Rojas F, Restrepo A, Hemmige V, Prasidthrathsint K, Cobb S, Herwaldt L, Raabe V, Cannavino CR, Hines AG, Bares SH, Antiporta PB, Scardina T, Patel U, Reid G, Mohazabnia P, Kachhdiya S, Le BM, Park CJ, Ostrowsky B, Robicsek A, Smith BA, Schied J, Bhatti MM, Mayer S, Sikka M, Murphy-Aguilu I, Patwari P, Abeles SR, Torriani FJ, Abbas Z, Toya S, Doktor K, Chakrabarti A, Doblecki-Lewis S, Looney DJ, David MZ.

J Clin Virol. 2016 Jul;80:12-9. doi: 10.1016/j.jcv.2016.04.008. Epub 2016 Apr 14.

PMID:
27130980
6.

Documenting Penicillin Allergy: The Impact of Inconsistency.

Shah NS, Ridgway JP, Pettit N, Fahrenbach J, Robicsek A.

PLoS One. 2016 Mar 16;11(3):e0150514. doi: 10.1371/journal.pone.0150514. eCollection 2016.

7.

Performance characteristics and associated outcomes for an automated surveillance tool for bloodstream infection.

Ridgway JP, Sun X, Tabak YP, Johannes RS, Robicsek A.

Am J Infect Control. 2016 May 1;44(5):567-71. doi: 10.1016/j.ajic.2015.12.044. Epub 2016 Feb 18.

PMID:
26899530
8.

Complex Cases in Abdominal Wall Repair and Prophilactic Mesh.

Kubota T, Mizuta T, Katagiri H, Shimaguchi M, Okumura K, Sakamoto T, Sakata T, Kunisaki S, Matsumoto R, Nishida K, Schaprynsky V, Vorovsky O, Romanchuk V, Basta M, Fischer J, Wink J, Kovach S, Tan WB, Tang SW, Clara ES, Hu J, Wijerathne S, Cheah WK, Shabbir A, Lomanto D, Siawash M, de Jager-Kieviet JW, Tjon A Ten W, Roumen RM, Scheltinga MR, van Assen T, Boelens OB, van Eerten PV, Perquin C, DeAsis F, Salabat M, Leung D, Schindler N, Robicsek A, Denham W, Ujiki M, Bauder A, Mackay D, Maggiori L, Moszkowicz D, Zappa M, Mongin C, Panis Y, Köhler G, Hofmann A, Lechner M, Mayer F, Emmanuel K, Fortelny R, Gruber-Blum S, May C, Glaser K, Redl H, Petter-Puchner A, Narang S, Alam N, Campain N, McGrath J, Daniels IR, Smart NJ.

Hernia. 2015 Apr;19 Suppl 1:S133-7. doi: 10.1007/BF03355340. No abstract available.

PMID:
26518790
9.

Nonimpact of Decolonization as an Adjunctive Measure to Contact Precautions for the Control of Methicillin-Resistant Staphylococcus aureus Transmission in Acute Care.

Peterson LR, Wright MO, Beaumont JL, Komutanon V, Patel PA, Schora DM, Schmitt BH, Robicsek A.

Antimicrob Agents Chemother. 2015 Oct 12;60(1):99-104. doi: 10.1128/AAC.02046-15. Print 2016 Jan.

10.

Severe Influenza in 33 US Hospitals, 2013-2014: Complications and Risk Factors for Death in 507 Patients.

Shah NS, Greenberg JA, McNulty MC, Gregg KS, Riddell J, Mangino JE, Weber DM, Hebert CL, Marzec NS, Barron MA, Chaparro-Rojas F, Restrepo A, Hemmige V, Prasidthrathsint K, Cobb S, Herwaldt L, Raabe V, Cannavino CR, Hines AG, Bares SH, Antiporta PB, Scardina T, Patel U, Reid G, Mohazabnia P, Kachhdiya S, Le BM, Park CJ, Ostrowsky B, Robicsek A, Smith BA, Schied J, Bhatti MM, Mayer S, Sikka M, Murphy-Aguilu I, Patwari P, Abeles SR, Torriani FJ, Abbas Z, Toya S, Doktor K, Chakrabarti A, Doblecki-Lewis S, Looney DJ, David MZ.

Infect Control Hosp Epidemiol. 2015 Nov;36(11):1251-60. doi: 10.1017/ice.2015.170. Epub 2015 Jul 30.

PMID:
26224364
11.

Evaluating Primary Care Physician Performance in Diabetes Glucose Control.

Brown EC, Robicsek A, Billings LK, Barrios B, Konchak C, Paramasivan AM, Masi CM.

Am J Med Qual. 2016 Sep;31(5):392-9. doi: 10.1177/1062860615585138. Epub 2015 Apr 28.

PMID:
25921589
12.

Evaluation of multiple real-time PCR tests on nasal samples in a large MRSA surveillance program.

Patel PA, Robicsek A, Grayes A, Schora DM, Peterson KE, Wright MO, Peterson LR.

Am J Clin Pathol. 2015 May;143(5):652-8. doi: 10.1309/AJCPMDY32ZTDXPFC.

PMID:
25873498
13.

Clinical decision support systems and infection prevention: to know is not enough.

Wright MO, Robicsek A.

Am J Infect Control. 2015 Jun;43(6):554-8. doi: 10.1016/j.ajic.2015.02.004. Epub 2015 Mar 19. Review.

PMID:
25798779
14.

Active Surveillance and Decolonization Without Isolation Is Effective in Preventing Methicillin-Resistant Staphylococcus aureus Transmission in the Psychiatry Units.

Das S, Harazin M, Wright MO, Dusich I, Robicsek A, Peterson LR.

Open Forum Infect Dis. 2014 Aug 19;1(2):ofu067. doi: 10.1093/ofid/ofu067. eCollection 2014 Sep.

15.

Outpatient advance care planning for patients with metastatic cancer: a pilot quality improvement initiative.

Obel J, Brockstein B, Marschke M, Robicsek A, Konchak C, Sefa M, Ziomek N, Benfield T, Peterson C, Gustafson C, Eriksson J, Harper A, Tabachow C, Raymond M, Hensing T.

J Palliat Med. 2014 Nov;17(11):1231-7. doi: 10.1089/jpm.2014.0085. Epub 2014 Oct 24.

PMID:
25343403
16.

Multidrug-resistant organisms contaminating supply carts of contact isolation patients.

Zelencik S, Schora D, Fisher A, Brudner C, Patel P, Robicsek A, Smith B, Peterson LR, Wright MO.

Am J Infect Control. 2014 Oct;42(10):1124-6. doi: 10.1016/j.ajic.2014.06.009.

PMID:
25278409
17.

Sensitivity of surveillance testing for multidrug-resistant Gram-negative bacteria in the intensive care unit.

Ridgway JP, Peterson LR, Thomson RB Jr, Miller BA, Wright MO, Schora DM, Robicsek A.

J Clin Microbiol. 2014 Nov;52(11):4047-8. doi: 10.1128/JCM.02369-14. Epub 2014 Aug 20.

18.

Multicenter development and validation of a risk stratification tool for ward patients.

Churpek MM, Yuen TC, Winslow C, Robicsek AA, Meltzer DO, Gibbons RD, Edelson DP.

Am J Respir Crit Care Med. 2014 Sep 15;190(6):649-55. doi: 10.1164/rccm.201406-1022OC.

19.

Predictive utility of prior positive urine cultures.

MacFadden DR, Ridgway JP, Robicsek A, Elligsen M, Daneman N.

Clin Infect Dis. 2014 Nov 1;59(9):1265-71. doi: 10.1093/cid/ciu588. Epub 2014 Jul 21.

PMID:
25048850
20.

A technology-based quality innovation to identify undiagnosed hypertension among active primary care patients.

Rakotz MK, Ewigman BG, Sarav M, Ross RE, Robicsek A, Konchak CW, Gavagan TF, Baker DW, Hyman DJ, Anderson KP, Masi CM.

Ann Fam Med. 2014 Jul;12(4):352-8. doi: 10.1370/afm.1665.

21.

Reply to Daniell.

Hebert C, Robicsek A.

Infect Control Hosp Epidemiol. 2014 Jan;35(1):94-5. doi: 10.1086/674401. No abstract available.

PMID:
24334807
22.

Clinical significance of methicillin-resistant Staphylococcus aureus colonization on hospital admission: one-year infection risk.

Ridgway JP, Peterson LR, Brown EC, Du H, Hebert C, Thomson RB Jr, Kaul KL, Robicsek A.

PLoS One. 2013 Nov 20;8(11):e79716. doi: 10.1371/journal.pone.0079716. eCollection 2013.

23.

Molecular epidemiology of Escherichia coli sequence type 131 and Its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago Region, 2007 to 2010.

Banerjee R, Robicsek A, Kuskowski MA, Porter S, Johnston BD, Sokurenko E, Tchesnokova V, Price LB, Johnson JR.

Antimicrob Agents Chemother. 2013 Dec;57(12):6385-8. doi: 10.1128/AAC.01604-13. Epub 2013 Sep 30.

24.

Utility of prior screening for methicillin-resistant Staphylococcus aureus in predicting resistance of S. aureus infections.

MacFadden DR, Elligsen M, Robicsek A, Ricciuto DR, Daneman N.

CMAJ. 2013 Oct 15;185(15):E725-30. doi: 10.1503/cmaj.130364. Epub 2013 Sep 9.

25.

Predictors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli infection in a Midwestern community.

Banerjee R, Strahilevitz J, Johnson JR, Nagwekar PP, Schora DM, Shevrin I, Du H, Peterson LR, Robicsek A.

Infect Control Hosp Epidemiol. 2013 Sep;34(9):947-53. doi: 10.1086/671725. Epub 2013 Jul 17.

26.

Electronic health record-based detection of risk factors for Clostridium difficile infection relapse.

Hebert C, Du H, Peterson LR, Robicsek A.

Infect Control Hosp Epidemiol. 2013 Apr;34(4):407-14. doi: 10.1086/669864. Epub 2013 Feb 13.

PMID:
23466915
27.

Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli.

Johnson JR, Tchesnokova V, Johnston B, Clabots C, Roberts PL, Billig M, Riddell K, Rogers P, Qin X, Butler-Wu S, Price LB, Aziz M, Nicolas-Chanoine MH, Debroy C, Robicsek A, Hansen G, Urban C, Platell J, Trott DJ, Zhanel G, Weissman SJ, Cookson BT, Fang FC, Limaye AP, Scholes D, Chattopadhyay S, Hooper DC, Sokurenko EV.

J Infect Dis. 2013 Mar 15;207(6):919-28. doi: 10.1093/infdis/jis933. Epub 2013 Jan 3.

28.

Epidemiology of methicillin-resistant Staphylococcus aureus carriage and MRSA surgical site infections in patients undergoing colorectal surgery: a cohort study in two centers.

Huttner B, Robicsek AA, Gervaz P, Perencevich EN, Schiffer E, Schrenzel J, Harbarth S.

Surg Infect (Larchmt). 2012 Dec;13(6):401-5. doi: 10.1089/sur.2011.107. Epub 2012 Dec 16.

29.

Continuous passive disinfection of catheter hubs prevents contamination and bloodstream infection.

Wright MO, Tropp J, Schora DM, Dillon-Grant M, Peterson K, Boehm S, Robicsek A, Peterson LR.

Am J Infect Control. 2013 Jan;41(1):33-8. doi: 10.1016/j.ajic.2012.05.030. Epub 2012 Oct 17.

PMID:
23084024
30.

Objective surveillance definitions for ventilator-associated pneumonia.

Klompas M, Magill S, Robicsek A, Strymish JM, Kleinman K, Evans RS, Lloyd JF, Khan Y, Yokoe DS, Stevenson K, Samore M, Platt R; CDC Prevention Epicenters Program.

Crit Care Med. 2012 Dec;40(12):3154-61. doi: 10.1097/CCM.0b013e318260c6d9.

PMID:
22990454
31.

The influence of context on antimicrobial prescribing for febrile respiratory illness: a cohort study.

Hebert C, Beaumont J, Schwartz G, Robicsek A.

Ann Intern Med. 2012 Aug 7;157(3):160-9. doi: 10.7326/0003-4819-157-3-201208070-00005.

PMID:
22868833
32.

Electronic surveillance for infectious disease trend analysis following a quality improvement intervention.

Peterson KE, Hacek DM, Robicsek A, Thomson RB Jr, Peterson LR.

Infect Control Hosp Epidemiol. 2012 Aug;33(8):790-5. doi: 10.1086/666625. Epub 2012 Jun 11.

PMID:
22759546
33.

Impact of laboratory-reported urine culture colony counts on the diagnosis and treatment of urinary tract infection for hospitalized patients.

Kwon JH, Fausone MK, Du H, Robicsek A, Peterson LR.

Am J Clin Pathol. 2012 May;137(5):778-84. doi: 10.1309/AJCP4KVGQZEG1YDM.

PMID:
22523217
34.

Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009.

Johnson JR, Nicolas-Chanoine MH, DebRoy C, Castanheira M, Robicsek A, Hansen G, Weissman S, Urban C, Platell J, Trott D, Zhanel G, Clabots C, Johnston BD, Kuskowski MA; MASTER Investigators.

Emerg Infect Dis. 2012 Apr;18(4):598-607. doi: 10.3201/eid1804.111627.

35.

Demonstration of the weighted-incidence syndromic combination antibiogram: an empiric prescribing decision aid.

Hebert C, Ridgway J, Vekhter B, Brown EC, Weber SG, Robicsek A.

Infect Control Hosp Epidemiol. 2012 Apr;33(4):381-8. doi: 10.1086/664768.

PMID:
22418634
36.

Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009.

Johnson JR, Urban C, Weissman SJ, Jorgensen JH, Lewis JS 2nd, Hansen G, Edelstein PH, Robicsek A, Cleary T, Adachi J, Paterson D, Quinn J, Hanson ND, Johnston BD, Clabots C, Kuskowski MA; AMERECUS Investigators.

Antimicrob Agents Chemother. 2012 May;56(5):2364-70. doi: 10.1128/AAC.05824-11. Epub 2012 Feb 21.

37.

Identification, management, and clinical characteristics of hospitalized patients with influenza-like illness during the 2009 H1N1 influenza pandemic, Cook County, Illinois.

Metzger KE, Black SR, Jones RC, Nelson SR, Robicsek A, Trenholme GM, Lavin MA, Weber SG, Garcia-Houchins S, Landon E, Parada JP, Gerber SI.

Infect Control Hosp Epidemiol. 2011 Oct;32(10):998-1002. doi: 10.1086/661912. Epub 2011 Aug 30.

PMID:
21931250
38.

Laboratory testing for Clostridium difficile infection: light at the end of the tunnel.

Peterson LR, Mehta MS, Patel PA, Hacek DM, Harazin M, Nagwekar PP, Thomson RB Jr, Robicsek A.

Am J Clin Pathol. 2011 Sep;136(3):372-80. doi: 10.1309/AJCPTP5XKRSNXVIL.

PMID:
21846912
39.

Reporting catheter-associated urinary tract infections: denominator matters.

Wright MO, Kharasch M, Beaumont JL, Peterson LR, Robicsek A.

Infect Control Hosp Epidemiol. 2011 Jul;32(7):635-40. doi: 10.1086/660765.

PMID:
21666391
40.

Electronic prediction rules for methicillin-resistant Staphylococcus aureus colonization.

Robicsek A, Beaumont JL, Wright MO, Thomson RB Jr, Kaul KL, Peterson LR.

Infect Control Hosp Epidemiol. 2011 Jan;32(1):9-19. doi: 10.1086/657631. Epub 2010 Dec 1.

PMID:
21121818
41.

Decolonization therapy in infection control.

Hebert C, Robicsek A.

Curr Opin Infect Dis. 2010 Aug;23(4):340-5. doi: 10.1097/QCO.0b013e32833ae214. Review.

PMID:
20485164
42.

Significant impact of terminal room cleaning with bleach on reducing nosocomial Clostridium difficile.

Hacek DM, Ogle AM, Fisher A, Robicsek A, Peterson LR.

Am J Infect Control. 2010 Jun;38(5):350-3. doi: 10.1016/j.ajic.2009.11.003. Epub 2010 Jan 31.

PMID:
20123150
43.

Management of a multidrug-resistant Acinetobacter baumannii outbreak in an intensive care unit using novel environmental disinfection: a 38-month report.

La Forgia C, Franke J, Hacek DM, Thomson RB Jr, Robicsek A, Peterson LR.

Am J Infect Control. 2010 May;38(4):259-63. doi: 10.1016/j.ajic.2009.07.012. Epub 2009 Nov 8.

PMID:
19900737
44.

Plasmid-mediated quinolone resistance: a multifaceted threat.

Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A.

Clin Microbiol Rev. 2009 Oct;22(4):664-89. doi: 10.1128/CMR.00016-09. Review.

45.
46.

Does my patient have Clostridium difficile infection?

Peterson LR, Robicsek A.

Ann Intern Med. 2009 Aug 4;151(3):176-9.

PMID:
19652187
47.

Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk.

Robicsek A, Beaumont JL, Thomson RB Jr, Govindarajan G, Peterson LR.

Infect Control Hosp Epidemiol. 2009 Jul;30(7):623-32. doi: 10.1086/597550.

PMID:
19496730
48.

Chromogenic media vs real-time PCR for nasal surveillance of methicillin-resistant Staphylococcus aureus: impact on detection of MRSA-positive persons.

Paule SM, Mehta M, Hacek DM, Gonzalzles TM, Robicsek A, Peterson LR.

Am J Clin Pathol. 2009 Apr;131(4):532-9. doi: 10.1309/AJCP18ONZUTDUGAQ.

PMID:
19289589
49.

The electronic medical record as a tool for infection surveillance: successful automation of device-days.

Wright MO, Fisher A, John M, Reynolds K, Peterson LR, Robicsek A.

Am J Infect Control. 2009 Jun;37(5):364-370. doi: 10.1016/j.ajic.2008.11.003. Epub 2009 Mar 9.

PMID:
19269712
50.

Duration of colonization with methicillin-resistant Staphylococcus aureus.

Robicsek A, Beaumont JL, Peterson LR.

Clin Infect Dis. 2009 Apr 1;48(7):910-3. doi: 10.1086/597296.

PMID:
19231982

Supplemental Content

Loading ...
Support Center